Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why ...

Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, offering a unique potential to selectively target malignant cells while sparing normal tissues.

The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients ...

The idea of turning back the clock on the immune system has moved from science fiction to a concrete experimental strategy. A ...